The pooled OR analysis revealed a significantly improved ORR in patients with PD‐L1‐positive HCC compared with patients with PD‐L1‐negative HCC (OR, 1.86, 95% CI, 1.35–2.55; p < 0.001) (Figure 1). The gene discussed is CD274; the disease is hepatocellular carcinoma.